Sarah Feldman

Brigham and Women's Hospital

Papers

2

Total Citations

105

H-Index

2

About

Dr. Sarah Feldman is a leading gynecologic oncologist whose research has fundamentally reshaped surgical approaches to cervical cancer. Her primary focus lies in evaluating the safety and efficacy of minimally invasive surgical techniques, particularly radical hysterectomy, against traditional open laparotomy. Dr. Feldman’s landmark 2016 study, cited over 100 times, provided pivotal evidence that minimally invasive radical hysterectomy is associated with significantly reduced patient morbidity—including less blood loss, shorter hospital stays, and fewer complications—while achieving comparable survival outcomes to the more invasive laparotomy. This work challenged long-standing surgical dogma and has directly influenced clinical guidelines, offering thousands of women a less traumatic path to recovery without compromising oncologic safety. Beyond this cornerstone contribution, her research portfolio consistently emphasizes patient-centered outcomes and the rigorous comparative effectiveness of surgical innovations. Dr. Feldman’s scholarship has not only advanced the field of gynecologic oncology but has also set a new standard for evidence-based surgical decision-making, making her a respected voice in the ongoing evolution of cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
105
Total Citations
53
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Radical Hysterectomy for Cervical Cancer Is Associated With Reduced Morbidity and Similar Survival Outcomes Compared With Laparotomy
103 citations · 2016
📈 Most Prolific Year: 2016 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Brigham and Women's Hospital

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago